BamSEC and AlphaSense Join Forces
Learn More

Leap Therapeutics Inc.

NASDAQ: LPTX    
Share price (1/8/25): $3.38    
Market cap (1/8/25): $130 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 10-Q 3 pages Certificate of Elimination of the Series X Non-Voting Convertible Preferred Stock of Leap Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 10-Q 3 pages Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation of Leap Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Certificate of Designation of Special Voting Stock of Leap Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 17 pages Leap Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series X Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from 8-K 6 pages Fourth Amended and Restated Certificate of Incorporation of Leap Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 3 pages Certificate of Elimination of the Series B Preferred Stock of Leap Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of the Series a Preferred Stock of Leap Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.2
from 10-Q 2 pages Certificate of Amendment to Third Amended and Restated Certificate of Incorporation of Leap Therapeutics, Inc
12/34/56
EX-3.3
from 8-K 5 pages Certificate of Designation of Special Voting Stock of Leap Therapeutics, Inc. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 13 pages Certificate of Designation of Series B Mandatorily Convertible Cumulative Non-Voting Perpetual Preferred Stock of Leap Therapeutics, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 12 pages Certificate of Designation of Series a Mandatorily Convertible Cumulative Non-Voting Perpetual Preferred Stock of Leap Therapeutics, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 7 pages Third Amended and Restated Certificate of Incorporation of Leap Therapeutics, Inc
12/34/56
EX-3.2
from S-4 14 pages Dekkun Corporation B Y - L a W S
12/34/56
EX-3.1
from S-4 25 pages First Amended and Restated Certificate of Incorporation of Leap Therapeutics, Inc
12/34/56